What is the long-term trend for Baxter International's indefinite- lived intangible impairment?

Over 5 years (2020 to 2025), Baxter International's indefinite- lived intangible impairment has grown at a 19.2% compound annual growth rate (CAGR), from $3.38B to $8.14B.

Baxter International BAX Indefinite- lived intangible impairment

Indefinite- lived intangible impairment at other companies

Medline, Inc. MDLN

——

AbbVieABBV

——

Merck & Co.MRK

——

ViatrisVTRS

——

Tenet HealthcareTHC

——

Other financials

Income statement

See full

Revenue$2.7B+2.9%

Gross profit$891.0M+3.5%

Operating income$66.0M+13.8%

Net income-$15.0M-112%

EPS (diluted)-$0.03-112%

Balance sheet

See full

Cash & equivalents$2.0B-12.1%

Total debt$224.0M-8.9%

Total equity$6.0B-14.7%

Total assets$19.8B-6.8%

Cash flow

See full

Operating cash flow$213.0M+210%

CapEx$128.3M+15.0%

Free cash flow$83.0M-42.1%

Valuation

See full

Market cap$10.27B-50.6%

Enterprise value$8.48B-55.6%

P/S0.9×-1.0×

Profitability

See full

Gross margin30.1%-5.9pp

Operating margin-2.7%—

Net margin-9.7%+62.5pp

FCF margin3%-2.4pp

Returns & leverage

See full

Return on equity-16.7%-76.7pp

Debt / equity0×0.0×

Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsGrossExcludingGoodwill.

The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's indefinite- lived intangible impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Baxter International's indefinite- lived intangible impairment?: Baxter International (BAX) reported indefinite- lived intangible impairment of $8.13B in Q1 2026.
How has Baxter International's indefinite- lived intangible impairment changed year-over-year?: Baxter International's indefinite- lived intangible impairment decreased by 2.9% year-over-year, from $8.37B to $8.13B.
What is the long-term trend for Baxter International's indefinite- lived intangible impairment?: Over 5 years (2020 to 2025), Baxter International's indefinite- lived intangible impairment has grown at a 19.2% compound annual growth rate (CAGR), from $3.38B to $8.14B.